SARS-CoV E2 Glycoprotein Antikörper

Produktnummer ABIN1724638

Produktdetails anti-SARS-CoV E2 Glycoprotein Antikörper

Target: SARS-CoV E2 Glycoprotein (SARS-CoV E2) (SARS-Coronavirus E2 Glycoprotein (SARS-CoV E2))

Reaktivität: SARS Coronavirus (SARS-CoV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser SARS-CoV E2 Glycoprotein Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Aufreinigung: purified

Immunogen: Purified recombinant fragment of SARS-E2 glycoprotein precursor expressed in E. coli.

Klon: 4A6C9

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA: 1:10000, WB: 1:500 - 1:2000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Subclonal supernatant.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: 4°C, -20°C for long term storage

Details zu SARS-CoV E2 Glycoprotein

Target: SARS-CoV E2 Glycoprotein (SARS-CoV E2) (SARS-Coronavirus E2 Glycoprotein (SARS-CoV E2))

Andere Bezeichnung: SARS-E2 (SARS-CoV E2 Produkte)

Substanzklasse: Viral Protein

Hintergrund:

Description: SARS (severe acute respiratory syndrome) is caused by a human coronavirus. Human coronaviruses are the major cause of upper respiratory tract illness, such as the common cold, in humans. Coronaviruses are positive-stranded RNA viruses, featuring the largest viral RNA genomes known to date (27-31 kb). The complete sequence of the SARS virus release the coronavirus contains 25 open reading frames. SARS-E2 glycoprotein precursor is a 139- kDa glycoprotein. It contains a superantigen between residues 690 through 1050 which has relationship to T-cell Receptor alpha-beta V chain protein.

Aliases: N/A